International
The Morning Science

What science found today

‹
 

Research

Omalizumab Linked With Anaphylaxis Elimination in Meat Allergy

MedPage Today ·

Omalizumab Linked With Anaphylaxis Elimination in Meat Allergy

The Brief

  • In one case series, omalizumab (Xolair) appeared to eliminate anaphylaxis risk in patients with alpha-gal syndrome who still had severe allergic reactions to red meat despite avoiding it.
  • The finding comes from a case series reported in MedPage Today's coverage of an ACAAI meeting, not from a controlled trial.

Why it matters

Alpha-gal syndrome is a meat allergy linked to tick bites, and patients who cannot control reactions by avoidance have few options. If confirmed, omalizumab could be a treatment option for these patients, but the evidence so far comes from a case series.

Who’s affected

  • clinicians and allergists treating alpha-gal syndrome
  • patients with alpha-gal syndrome who have severe reactions despite avoiding red meat
  • #allergy
  • #alpha-gal
  • #omalizumab
  • #anaphylaxis
  • #meat-allergy

(MedPage Today) -- For patients with alpha-gal syndrome who had severe allergic reactions to red meat despite avoidance, treatment with omalizumab (Xolair) appeared to eliminate anaphylaxis risk in one case series. Whereas 53% of 64 such patients...

How do you feel about this?

0 Comments

    Omalizumab Linked With Anaphylaxis Elimination in Meat Allergy – The Morning Science